Francesco Bellinato Selected Research

Francesco Bellinato Research Topics

Disease

19	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024 - 01/2020
6	Infections 01/2024 - 12/2020
4	COVID-19 10/2023 - 09/2021
4	Psoriatic Arthritis 10/2022 - 01/2022
2	Skin Diseases (Skin Disease) 10/2022 - 12/2020
2	Obesity 06/2022 - 06/2022
1	Alopecia Areata 05/2024
1	Melanoma (Melanoma, Malignant) 01/2024
1	Bites and Stings (Sting) 01/2024
1	Tuberculosis (Tuberculoses) 01/2024
1	Latent Tuberculosis 01/2024
1	Atopic Dermatitis (Atopic Eczema) 06/2023
1	Pain (Aches) 03/2023
1	Cicatrix (Scar) 10/2022
1	Disease Progression 10/2022
1	Noncommunicable Diseases 06/2022
1	Hypoxia (Hypoxemia) 06/2022
1	Inflammation (Inflammations) 06/2022
1	Ketosis 06/2022
1	Kwashiorkor 06/2022
1	Mouth Neoplasms (Oral Cancer) 06/2022
1	Periodontal Diseases (Periodontal Disease) 06/2022
1	Periodontitis 06/2022
1	Protein-Energy Malnutrition (Marasmus) 06/2022
1	Vitamin A Deficiency 06/2022
1	Kimura Disease 01/2022
1	Enthesopathy 01/2022
1	Urethritis 12/2021
1	Urticaria (Hives) 11/2021
1	Hypertension (High Blood Pressure) 10/2021
1	Dyslipidemias (Dyslipidemia) 10/2021
1	Exanthema (Rash) 09/2021
1	Cardiotoxicity 09/2021
1	Alopecia (Baldness) 06/2021
1	Erythema 01/2021

Drug/Important Bio-Agent (IBA)

4	Biosimilar PharmaceuticalsIBA 12/2022 - 01/2021
3	VaccinesIBA 12/2022 - 12/2020
3	Adalimumab (Humira)FDA Link 12/2022 - 04/2022
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2021
2	Interleukin-17 (Interleukin 17)IBA 01/2024 - 01/2021
2	dupilumabIBA 06/2023 - 01/2022
2	Methotrexate (Mexate)FDA LinkGeneric 12/2022 - 11/2020
2	secukinumabIBA 04/2022 - 11/2020
1	Janus Kinase InhibitorsIBA 05/2024
1	Lamivudine (Epivir)FDA Link 01/2024
1	cabotegravirIBA 01/2024
1	B7-H1 AntigenIBA 01/2024
1	InterferonsIBA 01/2024
1	doravirineIBA 01/2024
1	ixekizumabIBA 01/2024
1	Interleukin-23 (Interleukin 23)IBA 01/2024
1	Tumor Necrosis Factor InhibitorsIBA 01/2024
1	Monoclonal AntibodiesIBA 01/2024
1	spesolimabIBA 01/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2023
1	ABP 501IBA 12/2022
1	COVID-19 VaccinesIBA 12/2022
1	CytokinesIBA 10/2022
1	InterleukinsIBA 10/2022
1	FlavonoidsIBA 06/2022
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 06/2022
1	CyclodextrinsIBA 06/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 06/2022
1	IodineIBA 06/2022
1	IronIBA 06/2022
1	Leukotriene B4IBA 06/2022
1	Nerve Growth Factors (Neurotrophins)IBA 06/2022
1	TanninsIBA 06/2022
1	ZincIBA 06/2022
1	XenobioticsIBA 06/2022
1	LignansIBA 06/2022
1	MicronutrientsIBA 06/2022
1	PolyphenolsIBA 06/2022
1	EndocannabinoidsIBA 06/2022
1	Benzene (Benzole)IBA 01/2022
1	Antirheumatic Agents (DMARD)IBA 01/2022
1	Nitrogen DioxideIBA 01/2022
1	Particulate MatterIBA 01/2022
1	Nitrogen OxidesIBA 01/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	Carbon MonoxideIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Air Pollutants (Pollutants, Air)IBA 01/2022
1	Nucleic AcidsIBA 12/2021
1	Omalizumab (Xolair)FDA Link 11/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 10/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 09/2021
1	Doxycycline (Periostat)FDA LinkGeneric 06/2021
1	GP2015IBA 01/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021
1	Etanercept (Enbrel)FDA Link 01/2021
1	AntibodiesIBA 01/2021

Therapy/Procedure

7	Therapeutics 03/2023 - 01/2020
3	Biological Therapy 01/2024 - 08/2021
1	Chemoprevention 01/2024
1	Drug Therapy (Chemotherapy) 10/2022
1	Mediterranean Diet 06/2022
1	Phototherapy (Light Therapy) 01/2022